{"id":"https://openalex.org/W2097976367","doi":"https://doi.org/10.1200/jco.2006.08.5415","title":"Targeted Therapy for Metastatic Renal Cell Carcinoma","display_name":"Targeted Therapy for Metastatic Renal Cell Carcinoma","publication_year":2006,"publication_date":"2006-12-08","ids":{"openalex":"https://openalex.org/W2097976367","doi":"https://doi.org/10.1200/jco.2006.08.5415","mag":"2097976367","pmid":"https://pubmed.ncbi.nlm.nih.gov/17158546"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.08.5415","doi":"https://doi.org/10.1200/jco.2006.08.5415","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.08.5415","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059063118","display_name":"Robert John Motzer","orcid":"https://orcid.org/0000-0001-6925-2327","observed_orcids":["https://orcid.org/0000-0001-6925-2327"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I36373038","display_name":"Cleveland Clinic Lerner College of Medicine","ror":"https://ror.org/02x4b0932","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750","https://openalex.org/I36373038"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Motzer","raw_affiliation_strings":["From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, the Memorial Sloan-Kettering Cancer Center, New York, NY; and the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, the Memorial Sloan-Kettering Cancer Center, New York, NY; and the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I36373038","https://openalex.org/I58956616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112418138","display_name":"Ronald M. Bukowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I36373038","display_name":"Cleveland Clinic Lerner College of Medicine","ror":"https://ror.org/02x4b0932","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750","https://openalex.org/I36373038"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald M. Bukowski","raw_affiliation_strings":["From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, the Memorial Sloan-Kettering Cancer Center, New York, NY; and the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, the Memorial Sloan-Kettering Cancer Center, New York, NY; and the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I36373038","https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.3277,"has_fulltext":false,"cited_by_count":456,"citation_normalized_percentile":{"value":0.98821549,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"24","issue":"35","first_page":"5601","last_page":"5608"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8309999704360962},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.8059999942779541},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/vhl-tumor-suppressor-gene","display_name":"VHL tumor suppressor","score":0.9399999976158142},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor-1alpha","display_name":"hypoxia-inducible factor-1\u03b1","score":0.9810000061988831},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9959999918937683},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.6710000038146973},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.765999972820282},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7649999856948853},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8270000219345093},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8769999742507935},{"id":"https://openalex.org/keywords/fda-approval","display_name":"FDA approval","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.9666318297386169},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9527008533477783},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.9315288662910461},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8910437822341919},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.819225549697876},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.7036397457122803},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.6153233051300049},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5844715237617493},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5133732557296753},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.45794931054115295},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44504380226135254},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.413277804851532},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2374109923839569},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.18926307559013367},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.1605052947998047},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15743884444236755},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.12288272380828857},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.07578885555267334},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.057956963777542114},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077210","descriptor_name":"Sunitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001557","descriptor_name":"Benzenesulfonates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001557","descriptor_name":"Benzenesulfonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051794","descriptor_name":"Von Hippel-Lindau Tumor Suppressor Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051794","descriptor_name":"Von Hippel-Lindau Tumor Suppressor Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/jco.2006.08.5415","doi":"https://doi.org/10.1200/jco.2006.08.5415","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.08.5415","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:17158546","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17158546","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1004.5761","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1004.5761","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://hwmaint.jco.ascopubs.org/cgi/reprint/24/35/5601.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W117475386","https://openalex.org/W1533555842","https://openalex.org/W1880365120","https://openalex.org/W1944007521","https://openalex.org/W1966535797","https://openalex.org/W1970476748","https://openalex.org/W1997813173","https://openalex.org/W2013647024","https://openalex.org/W2014582878","https://openalex.org/W2015344488","https://openalex.org/W2015644147","https://openalex.org/W2021748258","https://openalex.org/W2041098455","https://openalex.org/W2046507292","https://openalex.org/W2051494228","https://openalex.org/W2068555261","https://openalex.org/W2072839085","https://openalex.org/W2077858999","https://openalex.org/W2098136315","https://openalex.org/W2098176107","https://openalex.org/W2105677187","https://openalex.org/W2105984177","https://openalex.org/W2106453307","https://openalex.org/W2108366666","https://openalex.org/W2109735642","https://openalex.org/W2116177733","https://openalex.org/W2120129511","https://openalex.org/W2121306031","https://openalex.org/W2123334268","https://openalex.org/W2123784879","https://openalex.org/W2123914905","https://openalex.org/W2127768463","https://openalex.org/W2129701772","https://openalex.org/W2139236349","https://openalex.org/W2140765540","https://openalex.org/W2141577422","https://openalex.org/W2143782771","https://openalex.org/W2149026055","https://openalex.org/W2149268957","https://openalex.org/W2150162153","https://openalex.org/W2151414214","https://openalex.org/W2156408558","https://openalex.org/W2157019123","https://openalex.org/W2164452916","https://openalex.org/W2167041673","https://openalex.org/W2167786713","https://openalex.org/W2171469612","https://openalex.org/W2196592545","https://openalex.org/W2206164324","https://openalex.org/W2217399048","https://openalex.org/W2226259310","https://openalex.org/W2241421448","https://openalex.org/W2242921747","https://openalex.org/W2243165145","https://openalex.org/W2256356298","https://openalex.org/W2258874524","https://openalex.org/W2295043466","https://openalex.org/W2305352133","https://openalex.org/W2322553446","https://openalex.org/W2334694951","https://openalex.org/W2415587511","https://openalex.org/W2513233117","https://openalex.org/W2539182848","https://openalex.org/W2581755645","https://openalex.org/W2768600953","https://openalex.org/W2950942979","https://openalex.org/W3010916979","https://openalex.org/W3012375795","https://openalex.org/W3144462267","https://openalex.org/W4236703483","https://openalex.org/W4238826061","https://openalex.org/W4298379398"],"related_works":["https://openalex.org/W7101015720","https://openalex.org/W2102809491","https://openalex.org/W46296595","https://openalex.org/W378037398","https://openalex.org/W2049176627","https://openalex.org/W2470466748","https://openalex.org/W261847016","https://openalex.org/W2419293984","https://openalex.org/W3029283838","https://openalex.org/W2096264404"],"abstract_inverted_index":{"The":[0],"discovery":[1],"of":[2,23,42,80,169],"a":[3,31,71],"relationship":[4],"for":[5,33,64,167],"the":[6,21,40,61,81,93,101,161],"VHL":[7],"tumor":[8],"suppressor":[9],"gene,":[10],"hypoxia":[11],"inducible":[12],"factor-1":[13],"alpha,":[14],"and":[15,49,54,77,88,100,118,132,147,155,164],"vascular":[16],"endothelial":[17],"growth":[18,22],"factor":[19],"in":[20,68,109,122,144,176],"clear-cell":[24],"renal":[25],"cell":[26],"carcinoma":[27],"(RCC)":[28],"has":[29],"identified":[30],"pathway":[32],"novel":[34,65,82],"targeted":[35,66,83,95],"therapy.":[36,124],"This":[37],"study":[38],"evaluated":[39],"impact":[41],"these":[43],"agents":[44,67,84],"on":[45,73],"metastatic":[46],"RCC":[47],"(mRCC),":[48],"highlights":[50],"recent":[51],"phase":[52,75],"II":[53,76],"III":[55,78],"trials.":[56,111],"A":[57],"systematic":[58],"review":[59],"examined":[60],"clinical":[62,177],"data":[63],"mRCC,":[69,170],"with":[70,116,130,137],"focus":[72],"randomized":[74,110],"trials":[79],"sunitinib,":[85,97],"temsirolimus,":[86,98],"sorafenib,":[87,99],"bevacizumab.":[89],"Several":[90],"agents,":[91],"including":[92],"small-molecule":[94],"inhibitors":[96],"monoclonal":[102],"antibody":[103],"bevacizumab,":[104],"have":[105,149],"demonstrated":[106],"antitumor":[107],"activity":[108,113,143],"Superior":[112],"was":[114,128],"found":[115],"sunitinib":[117],"temsirolimus":[119],"versus":[120],"cytokines":[121],"first-line":[123],"Improved":[125],"progression-free":[126],"survival":[127],"reported":[129],"sorafenib":[131,156],"bevacizumab":[133],"given":[134],"second-line":[135],"compared":[136],"placebo.":[138],"Targeted":[139],"therapies":[140],"show":[141],"promising":[142],"this":[145],"disease,":[146],"they":[148],"been":[150],"changing":[151],"patient":[152],"management.":[153],"Sunitinib":[154],"were":[157],"recently":[158],"approved":[159],"by":[160],"US":[162],"Food":[163],"Drug":[165],"Administration":[166],"treatment":[168],"These":[171],"drugs":[172],"are":[173],"currently":[174],"included":[175],"practice.":[178]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":26},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":31},{"year":2012,"cited_by_count":30}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}